Our Industry Partners share the ESO mission to reduce the burden of Stroke. They also support ESO’s aim to improve stroke care by providing medical education.
We are pleased to inform you about the ESO-endorsed industry webinars.
Date: Thursday, 26 January 2023, 18:30 – 19:30 CET
Webinar Speakers & Topics:
Prof. Tsivgoulis – International Guidelines for AF detection in Cryptogenic Stroke, a comprehensive overview
Prof. Mutzenbach – Neurology-led management of cryptogenic stroke patients: from theory to practice
Dr. Toquero – Cardiology perspective about practical implementation of post Stroke screening
Professor Geert Jan Biessels,UMC Utrecht Brain Center, The Netherlands
The program focuses on the MDT roles in the management of diabetic patients with a history or risk of stroke. Featuring a short eLearning module along with an interactive webcast, the MDT faculty (made up of neurologists, an endocrinologist and a primary care practitioner) discuss newer drug classes showing benefit in primary and secondary prevention of stroke.
Professor Maurizio Paciaroni, University of Perugia Hospital, Italy
The objective of this webinar is to discuss the management and challenges of anticoagulation in elderly and co-morbid AF patients after intracerebral haemorrhage by reviewing clinical evidence from randomized trials, real-world evidence from daily practice and by discussing clinical guidelines and practical recommendations. Professor Paciaroni will reflect on both, the management of the acute phase after a cerebrovascular event as well as long-term secondary stroke prevention in this high risk AF patient group.
Prof. Urs Fischer, Switzerland, Moderator:
“Despite recent advances in technical equipment and overall increasing reperfusion quality, still 40% of acute ischemic patients with a large vessel occlusion show a non-complete reperfusion after mechanical thrombectomy. There is a strong association between reperfusion grade achieved and functional outcome, and patients with TICI3 have a significant better outcome than patients with TICI2b. Therefore, the ESO/ESMINT guidelines currently state: “Interventionalists should attempt a TICI3 reperfusion, if achievable with reasonable safety”. However, what has to be done “right”, to achieve TICI3 in all acute ischemic stroke patients? Don’t miss this webinar during which we will discuss about the “right patient”, the “right place”, the “right treatment”, and the “right technique”!”